Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-24 Purchase |
2023-05-26 4:20 pm |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
1,900 | $5.1528 | $9,790 | 2,715,145 (Indirect Direct) |
View |
| 2023-05-24 Purchase |
2023-05-25 4:07 pm |
Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. |
2,400 | $5.39 | $12,936 | 2,400 (Direct) |
View |
| 2023-05-23 Purchase |
2023-05-25 4:05 pm |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
5,000 | $5.5 | $27,500 | 42,165 (Direct) |
View |
| 2023-05-23 Purchase |
2023-05-25 4:03 pm |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
11,856 | $5.63 | $66,749 | 2,713,245 (Indirect Direct) |
View |
| 2023-05-22 Purchase |
2023-05-24 5:09 pm |
Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
869,565 | $5.75 | $4,999,999 | 10,646,056 (Indirect) |
View |
| 2023-05-22 Purchase |
2023-05-24 5:07 pm |
Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner |
869,565 | $5.75 | $4,999,999 | 10,646,056 (Indirect) |
View |
| 2023-04-06 Sale |
2023-04-06 6:19 pm |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
13,280 | $6.12 | $81,274 | 136,720 (Direct) |
View |
| 2022-12-20 Purchase |
2022-12-21 4:08 pm |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
19,188 | $5.1306 | $98,446 | 2,701,389 (Indirect Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 09:13 am |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
10,000 | $4.76 | $47,600 | 35,873 (Direct) |
View |
| 2022-06-01 Purchase |
2022-06-01 4:31 pm |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
10,000 | $4.23 | $42,300 | 24,500 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 5:20 pm |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $13 | $373,763 | 271,489 (Direct) |
View |
| 2021-12-13 Purchase |
2021-12-15 5:21 pm |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
8,000 | $11.86 | $94,880 | 268,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-16 Option Award |
2023-06-21 4:13 pm |
N/A 2033-06-15 |
Prelude Therapeutics Inc | PRLD | Dier Mardi Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:12 pm |
N/A 2033-06-15 |
Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:11 pm |
N/A 2033-06-15 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-05-22 Option Award |
2023-05-24 4:12 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
11,595,256 | $5.7499 | 18,765,329 (Indirect) |
View |
| 2023-05-22 Option Award |
2023-05-24 4:12 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
1,448,222 | $5.75 | 18,765,329 (Indirect) |
View |
| 2023-04-04 Exercise |
2023-04-06 6:19 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
37,500 | $0 | 136,720 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 4:06 pm |
N/A 2033-02-28 |
Prelude Therapeutics Inc | PRLD | Lim Bryant David Chief Legal Officer, Corp Sec. |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:08 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:08 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:07 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:07 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:07 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
330,000 | $0 | 330,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-22 4:05 pm |
N/A 2032-12-20 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:14 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | Sandor Victor Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:14 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | Dier Mardi Director |
34,300 | $0 | 34,300 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
31,293 | $0 | 31,293 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner |
34,300 | $0 | 34,300 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:06 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
34,300 | $0 | 34,300 (Indirect) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:46 pm |
N/A 2032-04-30 |
Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO |
610,000 | $0 | 610,000 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 5:08 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
36,062 | $1.89 | 354,839 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:08 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
36,062 | $0 | 354,839 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-22 6:01 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
6,500 | $7.51 | 14,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:12 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:11 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:09 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO |
327,900 | $0 | 327,900 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:08 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:07 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:11 pm |
N/A 2032-01-02 |
Prelude Therapeutics Inc | PRLD | Sandor Victor Director |
11,206 | $0 | 11,206 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
3,016 | $1.89 | 271,489 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
25,735 | $12.85 | 271,489 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 5:20 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs |
28,751 | $0 | 271,489 (Direct) |
View |